Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Senzime AB (SNZZF)
OTHER OTC:SNZZF
Holding SNZZF?
Track your performance easily
SNZZF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.42 - $0.97
Previous Close$0.58
Volume5.52K
Average Volume (3M)14.87K
Market Cap
$64.83M
Enterprise Value$60.85M
Total Cash (Recent Filing)kr58.39M
Total Debt (Recent Filing)kr14.67M
Price to Earnings (P/E)―
Beta0.56
Next Earnings
Feb 17, 2025EPS Estimate
-$0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.10
Shares OutstandingN/A
10 Day Avg. Volume22,748
30 Day Avg. Volume14,868
Standard Deviation0.22
R-Squared0.03
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)25.39
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Senzime AB News
SNZZF FAQ
What was Senzime AB’s price range in the past 12 months?
Senzime AB lowest stock price was $0.42 and its highest was $0.96 in the past 12 months.
What is Senzime AB’s market cap?
Currently, no data Available
When is Senzime AB’s upcoming earnings report date?
Senzime AB’s upcoming earnings report date is Feb 17, 2025 which is in 58 days.
How were Senzime AB’s earnings last quarter?
Senzime AB released its earnings results on Nov 06, 2024. The company reported -$0.024 earnings per share for the quarter, missing the consensus estimate of -$0.021 by -$0.003.
Is Senzime AB overvalued?
According to Wall Street analysts Senzime AB’s price is currently Overvalued.
Does Senzime AB pay dividends?
Senzime AB does not currently pay dividends.
What is Senzime AB’s EPS estimate?
Senzime AB’s EPS estimate is -$0.02.
How many shares outstanding does Senzime AB have?
Senzime AB has 113,335,660 shares outstanding.
What happened to Senzime AB’s price movement after its last earnings report?
Senzime AB reported an EPS of -$0.024 in its last earnings report, missing expectations of -$0.021. Following the earnings report the stock price went down -1.667%.
Which hedge fund is a major shareholder of Senzime AB?
Currently, no hedge funds are holding shares in SNZZF
---
Senzime AB Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-1.36%
12-Months-Change
Fundamentals
Return on Equity
-44.12%
Trailing 12-Months
Asset Growth
3.98%
Trailing 12-Months
Company Description
Senzime AB
Senzime AB engages in the development of enzyme-based biosensor technology for medical and biochemical processes and industries. It manufactures products for automated and continuous monitoring of life-critical substances such as glucose and lactate in both blood and tissues, as well as systems to monitor patient's neuromuscular function perioperatively and in the intensive care medicine setting. The company also distributes bioreactor systems for the pharmaceutical industry. Senzime was founded by Thomas Ambjorn Carlsson in 1999 and is headquartered in Uppsala, Sweden.
---
SNZZF Earnings Call
Q3 2024
0:00 / 0:00
---
Technical Analysis
---